Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Apr 2024)

Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter‐Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO‐IT)) Registry

  • Anna van Veelen,
  • Tom E. Verstraelen,
  • Yvemarie B. O. Somsen,
  • Joëlle Elias,
  • Ivo M. van Dongen,
  • Peter Paul H. M. Delnoy,
  • Marcoen F. Scholten,
  • Lucas V. A. Boersma,
  • Alexander H. Maass,
  • Sipke Strikwerda,
  • Mehran Firouzi,
  • Cornelis P. Allaart,
  • Kevin Vernooy,
  • Robert W. Grauss,
  • Raymond Tukkie,
  • Paul Knaapen,
  • Aeilko H. Zwinderman,
  • Marcel G. W. Dijkgraaf,
  • Bimmer E. P. M. Claessen,
  • Marit van Barreveld,
  • Arthur A. M. Wilde,
  • José P. S. Henriques

DOI
https://doi.org/10.1161/JAHA.123.032033
Journal volume & issue
Vol. 13, no. 8

Abstract

Read online

Background Chronic total coronary occlusions (CTO) substantially increase the risk for sudden cardiac death. Among patients with chronic ischemic heart disease at risk for sudden cardiac death, an implantable cardioverter defibrillator (ICD) is the favored therapy for primary prevention of sudden cardiac death. This study sought to investigate the impact of CTOs on the risk for appropriate ICD shocks and mortality within a nationwide prospective cohort. Methods and Results This is a subanalysis of the nationwide Dutch‐Outcome in ICD Therapy (DO‐IT) registry of primary prevention ICD recipients in The Netherlands between September 2014 and June 2016 (n=1442). We identified patients with chronic ischemic heart disease (n=663) and assessed available coronary angiograms for CTO presence (n=415). Patients with revascularized CTOs were excluded (n=79). The primary end point was the composite of all‐cause mortality and appropriate ICD shocks. Clinical follow‐up was conducted for at least 2 years. A total of 336 patients were included, with an average age of 67±9 years, and 20.5% was female (n=69). An unrevascularized CTO was identified in 110 patients (32.7%). During a median follow‐up period of 27 months (interquartile range, 24–32), the primary end point occurred in 21.1% of patients with CTO (n=23) compared with 11.9% in patients without CTO (n=27; P=0.034). Corrected for baseline characteristics including left ventricular ejection fraction, and the presence of a CTO was an independent predictor for the primary end point (hazard ratio, 1.82 [95% CI, 1.03–3.22]; P=0.038). Conclusions Within this nationwide prospective registry of primary prevention ICD recipients, the presence of an unrevascularized CTO was an independent predictor for the composite outcome of all‐cause mortality and appropriate ICD shocks.

Keywords